Shopping Cart
Remove All
Your shopping cart is currently empty
Zaurategrast (CDP323) is a small-molecule prodrug antagonist that inhibits the interaction between vascular cell adhesion molecule 1 (VCAM-1) and α4-integrins, originally developed by Celltech plc for oral administration, and it serves as a valuable research compound for investigating leukocyte trafficking, immune cell adhesion, and therapeutic strategies relevant to multiple sclerosis.

| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 1 mg | $69 | - | In Stock | |
| 5 mg | Preferential | - | In Stock |
| Description | Zaurategrast (CDP323) is a small-molecule prodrug antagonist that inhibits the interaction between vascular cell adhesion molecule 1 (VCAM-1) and α4-integrins, originally developed by Celltech plc for oral administration, and it serves as a valuable research compound for investigating leukocyte trafficking, immune cell adhesion, and therapeutic strategies relevant to multiple sclerosis. |
| Targets&IC50 | α4-integrin:< 100 nM |
| In vitro | Method: Pharmacokinetic properties of Zaurategrast were assessed using in vitro permeability and uptake assays and in vivo studies in mice, rats, dogs, and cynomolgus monkeys, followed by evaluation of an ethyl ester prodrug. Result: Zaurategrast showed low oral bioavailability in rodents and monkeys due to poor absorption and active hepatic uptake, while the prodrug CDP323 improved permeability and oral bioavailability with effective in vivo conversion[1]. |
| Synonyms | Zaurategrast, CT-7758, CT7758, CT 7758 |
| Molecular Weight | 521.41 |
| Formula | C26H25BrN4O3 |
| Cas No. | 455264-31-0 |
| Smiles | N([C@@H](CC1=CC=C(NC=2C3=C(C=CN2)C=CN=C3)C=C1)C(O)=O)C=4C5(C(=O)C4Br)CCCCC5 |
| Relative Density. | 1.31g/cm3 |
| Color | Yellow |
| Appearance | Solid |
| Storage | store at low temperature | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | |||||||||||||||||||||||||||||||||||
| Solubility Information | DMSO: 80 mg/mL (153.43 mM), Sonication is recommended. | |||||||||||||||||||||||||||||||||||
Solution Preparation Table | ||||||||||||||||||||||||||||||||||||
DMSO
| ||||||||||||||||||||||||||||||||||||
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.